ロード中...
Mineralocorticoid Receptor Antagonists
The role and adverse effects of mineralocorticoid receptor overactivation in the pathophysiology of heart failure (HF) is wellrecognised. MR antagonists (MRAs) have been tested in HF and shown to be effective in improving outcomes. Steroid-type MRAs spironolactone and eplerenone, have been proven to...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Barcaray International
2019-01-01
|
| シリーズ: | International Cardiovascular Forum Journal |
| 主題: | |
| オンライン･アクセス: | https://icfjournal.org/index.php/icfj/article/view/603/pdf |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|